Sensyne Health (SENS)

Sector:

Health Care

Index:

FTSE AIM All-Share

162.50p
   
  • Change Today:
    -1.00p
  • 52 Week High: 185.00
  • 52 Week Low: 29.35
  • Currency: UK Pounds
  • Shares Issued: 164.80m
  • Volume: 147,562
  • Market Cap: £267.80m
  • RiskGrade: 353
  • Beta: 0.00

Sensyne signs £0.5m Covid-19 test deal with DHSC

By Josh White

Date: Friday 12 Mar 2021

LONDON (ShareCast) - (Sharecast News) - Clinical artificial intelligence (AI) technology company Sensyne Health has signed a £0.47m agreement with the Department of Health and Social Care, it announced on Friday, to conduct the second stage of a pilot study of its 'MagnifEye' technology for use with Covid-19 lateral flow diagnostic tests.
The AIM-traded firm said the agreement followed the signing of an exclusive licence and development agreement with Excalibur Healthcare Services on 9 February, to apply MagnifEye for use with lateral flow rapid diagnostic tests.

"We are delighted to be working with the Department of Health and Social Care and Excalibur, and are happy to be able to contribute to the UK's Covid-19 testing programme by providing our MagnifEye technology for use with lateral flow diagnostic tests," said chief executive officer Lord Drayson.

"[We] look forward to the results of this pilot study."

At 0840 GMT, shares in Sensyne Health were up 4.32% at 175.25p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Sensyne Health Market Data

Currency UK Pounds
Share Price 162.50p
Change Today -1.00p
% Change -0.61 %
52 Week High 185.00
52 Week Low 29.35
Volume 147,562
Shares Issued 164.80m
Market Cap £267.80m
Beta 0.00
RiskGrade 353

Sensyne Health Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
51.56% below the market average51.56% below the market average51.56% below the market average51.56% below the market average51.56% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average
Price Trend
26.35% above the market average26.35% above the market average26.35% above the market average26.35% above the market average26.35% above the market average
43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average43.59% above the sector average
Income Not Available
Growth
46.47% above the market average46.47% above the market average46.47% above the market average46.47% above the market average46.47% above the market average
54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average54.84% above the sector average

What The Brokers Say

Strong Buy 2
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Sensyne Health Dividends

No dividends found

Trades for 07-May-2021

Time Volume / Share Price
15:48 74 @ 161.00p
15:33 13,735 @ 160.00p
15:20 50 @ 163.45p
15:13 250 @ 163.45p
14:40 605 @ 163.45p

Sensyne Health Key Personnel

CEO Paul Drayson

Top of Page